Cryptococcosis is an invasive fungal infection of humans and other animals, typically caused by the species Cryptococcus neoformans in patients with impaired immunity. However, there is growing recognition of the importance of the related species C. gattii in causing infections in apparently immunocompetent individuals. In particular, an ongoing outbreak of cryptococcal disease in the Pacific Northwest region, which started in 1999, has driven an intense research effort into this previously neglected pathogen. Here, we discuss some of the recent discoveries in this organism from the Pacific Northwest region and highlight areas for future investigation.

INTRODUCTION

Cryptococcus gattii is a fungal pathogen of humans and other animals that can be found both as an opportunistic infection (Hagen et al.2012) and as a primary pathogen (Kwon-Chung and Varma 2006). Cryptococcus gattii is a haploid, encapsulated basidiomycete yeast that is widespread in soil, trees and tree hollows (reviewed in Springer and Chaturvedi 2010; Harris, Lockhart and Chiller 2012).

Cryptococcosis is thought to commence upon inhalation of airborne infectious propagules, such as spores or dried yeast cells, allowing the pathogen to settle in the lungs, where it can survive and proliferate within alveolar macrophages (Fig. 1). Typical symptoms that are associated with cryptococcosis are fever, weight loss, fatigue, night sweats, cough, chest pain, headache, vomiting and neck stiffness (Phillips et al.2015). If the pathogen reaches the central nervous system, this can lead to meningoencephalitis, the most severe form of cryptococcosis, which is always lethal without rapid treatment.

Figure 1.

A schematic illustration of an infection process of C. gattii (left) and C. neoformans (right). An infection starts upon inhalation of airborne infectious propagules, which may allow the pathogen to settle in the lungs. If the fungus reaches the central nervous system, this can lead to a brain infection, which can be lethal. Note the differences between C. neoformans and C. gattii environmental origin, the immune condition of the hosts and organ preference between pathogens.

Interestingly, there is a predilection of C. neoformans for central nervous system infection and C. gattii for lung infection. On the other hand, pulmonary (and cerebral) cryptococcomas (large inflammatory masses) are formed during infection with C. gattii, but not with C. neoformans (Mitchell et al.1995; Chen et al.2000; Galanis et al.2010; Byrnes and Marr 2011); the latter leading instead mainly to small pulmonary lesions (Speed and Dunt 1995; Chen et al.2000). This might be due to higher transmigration of C. neoformans through brain blood barrier via the Trojan horse mechanism according to in vitro studies (Sorrell et al.2015).

Early reports describing patients suffering from cryptococcosis highlighted the prevalence of men over women (Chen et al.2000) which was thought due to the exposure of males to environmental sources. Recent data indicate that in fact presence of testosterone in men, but not β-estradiol in women, may influence capsule growth and reduce phagocytosis of yeast by macrophages (McClelland et al.2013; Costa et al.2015).

Interestingly, while C. neoformans mainly infects immunosuppressed patients, with HIV/AIDS being the most common underlying condition, C. gattii is considered as a primary pathogen, since it frequently infects immunocompetent and apparently healthy individuals (Speed and Dunt 1995; Sorrell 2001), although, recent studies suggest several factors such as smoking, oral corticosteroids usage and older age may increase the risk of infection by this species (reviewed in MacDougall et al.2011). Interestingly, anti-cryptococcal antibody levels are higher during C. gattii than C. neoformans infections in immunocompetent patients (Speed et al.1996) and in cats (Malik et al.1999), and thus it is possible that undiagnosed antibody deficiencies may predispose to C. gattii infections (Marr et al.2012). Similarly, high concentrations of granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies can be found in the plasma of otherwise healthy HIV-negative individuals suffering from cryptococcal meningitis (Rosen et al.2013) and, interestingly, are a significant risk factor for CNS infection by C. gattii but not C. neoformans (Saijo et al.2014).

In comparison to cryptococcosis caused by C. neoformans which kills 650 000 immunocompromised people suffering from HIV/AIDS every year worldwide (Park et al.2009) as well as a significant additional number of organ transplant recipients (Pappas 2013), C. gattii infections are rather rare, although recent studies indicate that they may be mis- or under-diagnosed (Iverson et al.2012; Tintelnot et al.2015). Cryptococcus gattii meningitis can be cured completely in the early stages of disease (Chen et al.2012), but often the disease is misdiagnosed as tuberculosis or other bacterial/viral pulmonary infections at this stage. Anti-fungal treatment is mainly based on amphotericin B in combination with 5-flucytosine and/or fluconazole (Chen et al.2013b) and at later stages of the disease surgery and corticosteroids may be required (Sorrell and Chen 2010).

There are many methods to differentiate between Cryptococcus species. Only C. gattii will produce blue colonies if grown on CGB (L-canavanine, glycine and bromthymol blue) agar (Kwon-Chung, Polacheck and Bennett 1982; Min and Kwon-Chung 1986). Similarly, capsular agglutination reactions can discriminate between C. neoformans, which exhibits serotypes A (C. neoformans var. grubii), D (C. neoformans var. neoformans) and AD and C. gattii (which is comprised of serotypes B and C (Kwon-Chung, Polacheck and Bennett 1982; Franzot, Salkin and Casadevall 1999; Boekhout et al.2001)). However, the most reliable methods for differentiating between Cryptococcus species are sequence based (McTaggart et al.2011; Kwon-Chung et al.2014; Hagen et al.2015) and rely on amplified fragment length polymorphism (AFLP; Boekhout et al.2001), PCR and multiplex PCR fingerprinting (Meyer et al.1999, 2003; Ito-Kuwa et al.2007) or sequencing of intergenic spacers (IGS; Diaz et al.2000, 2005).

For most of the time that cryptococcosis has been recognized, research efforts have focused on C. neoformans as the dominant pathogenic species. However, in 1999, an outbreak of cryptococcosis started on Vancouver Island (British Columbia, Canada) that was later identified as being caused by C. gattii. This outbreak subsequently spread to mainland Canada and the northwestern part of the USA (Oregon and Washington, MacDougall et al.2007). Although C. gattii was previously known to be prevalent in tropical regions (Kwon-Chung and Bennett 1984), its abrupt appearance in the moderate climate of the Pacific Northwest (PNW) region led to disease not only in otherwise healthy humans but also domestic, terrestrial and sea animals including dolphins (Stephen et al.2002; Kidd et al.2004; MacDougall et al.2007; Upton et al.2007). During 1999–2007, the outbreak affected 218 people (5.8 people per million in the region per year) and 19 died (8.7% associated deaths; Galanis et al.2010; Phillips et al.2015). In addition, during 2004—2011, the outbreak affected approximately 100 people, with a 33% mortality rate, in the US PNW (Harris et al.2011). Most people suffered from respiratory illness (76.6%) or lung cryptococcomas (75.4%; Galanis et al.2010), with a third of those patients also showing central nervous system infection (Phillips et al.2015).

97% of documented cryptococcosis cases from the Vancouver Island outbreak were compromised of molecular genotype VGII (VG = variety gattii; Boekhout et al.2001; Kidd et al.2004), with subtype VGIIa being responsible for 86.3% of cases in BC (Galanis et al.2010) and 81% in Washington/Oregon (Harris et al.2011). The remaining cases were caused by a closely related lineage, VGIIb (also termed the minor lineage; Kidd et al.2004), while a third lineage, VGIIc (novel) has been reported mainly from Oregon State (Harris et al.2011). VGIIa exhibits higher fertility than other C. gattii strains (Ngamskulrungroj et al.2008) and the molecular type is now considered as the most virulent within this species (Lizarazo et al.2014).

In comparison to non-outbreak isolates from Australia, where C. gattii is endemic, the majority of the Vancouver Island outbreak isolates were highly fertile (70% in BC versus 10% in Australia; Fraser et al.2003), hypervirulent (Fraser et al.2005) and showed low susceptibility to anti-fungal drugs (Trilles et al.2012). Although detailed analysis of many C. gattii isolates has been performed, no individual cryptococcal pathogenicity factors have yet been found (Ma et al.2009), leading to the suggestion that virulence is a complex, multifactorial phenotype (Garcia-Solache et al.2013; Firacative, Duan and Meyer 2014). Below we discuss some of the features of this pathogen which may contribute to this multifactorial pathogenicity.

ENVIRONMENTAL NICHE OF C. GATTII

While C. neoformans spores can be found in birds’ droppings, the environmental presence of C. gattii is strictly associated with plants. To date, 54 species of trees growing globally (Hagen and Boekhout 2010; Springer and Chaturvedi 2010) have been found to host C. gattii, with Australian eucalyptus (Ellis and Pfeiffer 1990), almond trees (Callejas et al.1998) in tropical and semi-tropical regions and, quite recently, Pseudotsuga menziesii (Oregon pine) in regions with a more moderate climate (Springer and Chaturvedi 2010) acting as dominant host species. Cryptococcus gattii can proliferate and mate on plant surfaces rich in myo-inositol (Xue et al.2007; Springer et al.2010) and there is some evidence that C. gattii may persist longer in the environment in the presence of plant tissue (Huerfano, Castaneda and Castaneda 2001).

THE ORIGIN OF THE PNW OUTBREAK

Early investigations proposed several sources for the VGII outbreak strain, but more recent work points to an origin in South America (VGIIa; Hagen et al.2013; Billmyre et al.2014; Engelthaler et al.2014) and Australia (VGIIb; (Fraser et al.2005; Billmyre et al.2014)). Separation of the VGI and VGII C. gattii strains occurred around 12.4 million years ago (D'Souza et al.2011), and this extended period of genetic isolation has contributed to recent suggestions to raise these lineages to species level (Hagen et al.2015). Although the molecular genotype of the VGII population differs significantly from other strains of C. gattii, due to mutations and recombinations, within the VGII group, the four subpopulations VGIIa, VGIIb, VGIIc and VGIIx are highly clonal and not very diverse (Billmyre et al.2014; Engelthaler et al.2014; Farrer et al.2015). A comparison between genomes from VGIIa isolates suggests that these groups diverged less than 100 years ago from a less virulent strain in which a frameshift mutation in a DNA repair gene msh2 was found (Billmyre et al.2014). VGIIa genomes from the outbreak do not contain the frameshift mutation, and it has been hypothesized that its genome reverted via mitotic microevolution (Billmyre et al.2014). If this is true, there is a possibility that the reversion occurred after gaining adaptation for higher virulence. Since the other non-pathogenic VGIIa-like isolates have retained this hypermutator mutation, it remains possible that such an event may recur leading to the emergence of novel outbreak strains (Billmyre et al.2014).

In addition, several studies have highlighted the potential for gene transfer (introgression) occurring between C. neoformans var. grubii and C. gattii (Engelthaler et al.2014) as well as between different C. gattii clades (Billmyre et al.2014) through sexual reproduction (bisexual or unisexual). Support for the latter model comes from evidence for genomic islands of high polymorphism within a VGIIa genome, which were potentially introduced from two distinct VGII clades (Billmyre et al.2014).

To date, all clonal C. gattii VGII isolates identified from the PNW have been mating type MATα (Lockhart et al.2013). Unlike MATa strains, MATα strains are capable of same-sex mating (Wiesner et al.2012) and this has been proposed as a potential origin for the PNW outbreak (Fraser et al.2005). In C. neoformans, MATα strains are also associated with higher virulence (Kwon-Chung, Edman and Wickes 1992; Barchiesi et al.2005; Nielsen et al.2005), but this appears not to be the case with C. gattii (Zhu et al.2013).

GENOMIC DIFFERENCES

Separation between the VGI and VGII C. gattii strains has resulted in significant genome differences including chromosomal rearrangements and higher than expected overall nucleotide sequence divergence (D'Souza et al.2011). Recently, a whole genome analysis was performed for all lineages of C. gattii (Farrer et al.2015), where the authors compared nuclear and mitochondrial DNAs between lineages. Interestingly, they found that the PNW outbreak VGII lost 146 genes (three times more than number of genes lost in VGI–III–IV lineages combined) that are still present in the three other lineages, including a mitochondrial cytochrome c peroxidase gene and several other genes that are typically thought of as being essential for nuclear and mitochondrial genome maintenance. At the same time, the VGII lineage has gained several unique genes encoding proteins with COX6B, HSP70 and iron-binding domains and proteins possibly involved in membrane trafficking.

LACK OF RNA INTERFERENCE MACHINERY

One of the most remarkable discoveries to emerge from the extensive genome sequencing effort in this species is the VGII-specific absence of genes encoding Argonaute, Ago1 and Ago2 (D'Souza et al.2011), which are critical components of the RNA interference (RNAi) machinery in other fungi including C. neoformans (Janbon et al.2010). This lack of ago genes was found in all VGII isolates, including those from beyond the PNW region (Farrer et al.2015). Thus, the C. gattii VGII lineage is lacking an RNAi-mediated genome defense during both the sexual cycle (Wang et al.2010; Dumesic et al.2013) and vegetative growth (Wang et al.2012). This loss of silencing machinery appears to have independently occurred in several pathogens (reviewed in Nicolas, Torres-Martinez and Ruiz-Vazquez 2013), a finding which remains enigmatic. However, this loss of RNAi typically leads to transposon reactivation, which may accelerate genome evolution and potentially help in developing novel anti-host mechanisms (Oliver and Greene 2009; Biemont 2010; Wang et al.2010). Alternatively, the loss of RNAi may be a protective response to pathogens that can otherwise hijack this pathway. Cross-kingdom hijacking of RNAi silencing is known for other pathogens, such as the plant fungal pathogen Botrytis cinerea which is able to hijack Arabidopsis and tomato RNAi machineries by binding to host AGO1, leading to the silencing of host immunity genes and facilitating infection (Weiberg et al.2013). To date, pathogens of Cryptococci have not been identified, but such a hypothesis remains at least a theoretical possibility.

FERTILITY

Although Cryptococci can reproduce sexually, where two opposite mating types, MATa and MATα, mate and produce spores, a predominance of α mating type in the environment means that alternative reproduction strategies are common. In particular, same-sex mating between two α mating-type parents (Lin, Hull and Heitman 2005), or spontaneous generation of spores by haploid strains (known as monokaryotic fruiting) can both produce infectious propagules. It has been suggested that the rapid expansion of the PNW outbreak has been driven primarily by clonal reproduction (Fraser et al.2005) and it is therefore enigmatic that the majority of the PNW outbreak isolates are highly fertile (Fraser et al.2003; Ngamskulrungroj et al.2008). Despite this, whole genome analysis has revealed very limited nuclear genetic exchange between C. gattii lineages (Farrer et al.2015), although interestingly several instances of recombination within the mitochondrial genome (Voelz et al.2013; Farrer et al.2015).

INFLAMMATION AND THE CYTOKINE RESPONSE

In contrast to C. neoformans, C. gattii is able to infect immunocompetent individuals, suggesting that the latter uses different or additional methods to inhibit immune responses. Somewhat counterintuitively, in human peripheral blood mononuclear cells, C. gattii induces higher concentrations of cytokines such as pro-inflammatory interleukin IL-1β, TNF- α and IL-6 and the T-cell cytokines IL-17 and IL-22 than C. neoformans (Schoffelen et al.2013). Interestingly, however, the authors found that Toll-like receptor (TLR) 4 and TLR9 were involved in the recognition of the pathogen, but not TLR2, unlike C. neoformans (Vecchiarelli 2005). These results suggested that a different innate cytokine response of the host might be related to different pathogen-activated molecular pattern (PAMPS) molecules localized on the C. gattii surface in comparison to C. neoformans. TLR2 is known to recognize chitin (Da Silva et al.2008). Chitin-like structures in Cryptococci are only exposed in the limited parts of the cell surface under the capsule (Rodrigues et al.2008b), which may be the reason why they are not normally recognized by TLR2. Thus it is possible that differences in the organization and localization of chitin-derived structures between C. neoformans and PNW C. gattii strains might explain different preferences in organ colonization, since C. gattii preferentially targets the lungs, whilst the brain is the primary target organ for C. neoformans (Ngamskulrungroj et al.2012; Sorrell et al.2015).

Although in vitro blood infections by C. gattii result in potent inflammatory signaling, in pulmonary tissue Hoang et al. found only minimal inflammatory responses to C. gattii (Hoang et al.2004). This may be accounted for by the ability of C. gattii to weaken pulmonary Th1 and Th17 responses (at least in mice) via altered dendritic cell (DC) function through down-regulation of pulmonary chemokine expression (Angkasekwinai et al.2014). This restricted DC function is related to reduced levels of TNF-α, and indeed addition of recombinant TNF-α fully restores DC maturation and thus T cell responses (Huston et al.2013).

Thus acute introduction of C. gattii may induce rapid inflammation, but longer lasting systemic inflammation is dampened by poor DC activation. This biphasic response may also explain otherwise contradictory findings, such as the relatively slower growth of C. gattii than C. neoformans in blood (Ngamskulrungroj et al.2012) (suggesting strong induction of defense) and yet reduced neutrophil infiltration to sites of infection (Cheng, Sham and Kronstad 2009).

VIRULENCE STRATEGIES

Human fungal pathogens often use a huge repertoire of virulence strategies in order to survive inside the host. In cryptococci, the polysaccharide capsule, chitin and melanin within the cell wall, phospholipases, urease, laccase and the ability to growth at 37°C are the most studied virulence factors involved in pathogenesis. However, although these features are shared by all pathogenic Cryptococci, there are some crucial differences among them that might play a role in the hypervirulence of PNW C. gattii isolates.

GROWTH AT 37°C

The ability to survive at elevated temperature is crucial for human pathogens. In Cryptococci, this is regulated by Calcineurin, a Ca2+/calmodulin-activated serine/threonine-specific phosphatase (Liu et al.1991). Typically, mutants lacking calcineurin gene, such as cna1Δ, are avirulent in both C. neoformans and C. gattii isolates. However, PNW VGIIa strains lacking calcineurin function are still viable at elevated temperature (Chen et al.2013a), suggesting there may be as-yet unidentified differences in temperature tolerance in this lineage.

CAPSULE

Cryptococcal capsule is a highly hydrated and a negatively charged mesh of polysaccharides surrounding the yeast cell (Fig. 2), mainly composed of glucuronoxylomannan (GXM; composed of mannose, xylose and glucuronic acid), and glucuronoxylomannogalactan (GXMGal) plus mannoproteins (Vartivarian et al.1989), and its growth is activated during host infection. Most studies to date have focused on C. neoformans capsule, which is considered a major virulence factor (McClelland, Bernhardt and Casadevall 2006) and has anti-phagocytic properties in macrophages (Kozel and Mastroianni 1976). This is correlated with a reduction of systemic inflammation (reviewed in Vecchiarelli et al.2013) mainly due to a suppression of T-lymphocyte proliferation (Syme et al.1999), induced secretion of the anti-inflammatory cytokine IL-10 (Vecchiarelli et al.1996) and inhibited secretion of TNF-α and IL-1β (Vecchiarelli et al.1995) by human monocytes.

Figure 2.

Diagram representing the role of cryptococcal polysaccharide capsule and its involvement in several immune responses. Chitin-like structures (not shown) composed of β-1,4-N-acetylglucosamine oligomers link the capsule to the cell wall (Rodrigues et al.2008a). GXMGal molecules (shown in red) are mainly found in growing capsules of budding daughter cell (De Jesus et al.2009) and also in the capsules of mature cells but only transiently due to secretion (De Jesus et al.2010).

GXM is a large molecule (around 4600 000 Daltons in serotype B strain I23) and has different structures (McFadden, De Jesus and Casadevall 2006) which correlate with differences in antibody reactivity (Fonseca et al.2010). Capsule size depends on environmental conditions (summarized in Zaragoza and Casadevall 2004; Gupta and Fries 2010) and capsule enlargement is usually observed during infection (Garcia-Hermoso, Dromer and Janbon 2004). This is linked to the presence of mammalian serum (Zaragoza et al.2003), higher CO2 concentration (Granger, Perfect and Durack 1985) and tissue-specific conditions such as iron deficiency in the lungs (Vartivarian et al.1993; Rivera et al.1998) or the high concentration of urea in cerebrospinal fluid (Frazzitta et al.2013). In addition, capsular size can change during the cell cycle and its enlargement is mainly observed during the G1 phase when no budding occurs (Garcia-Rodas et al.2014).

Depending on the C. gattii strain, age of the cells, temperature, conditions and methodology used for studies, capsule thickness can differ dramatically. For instance, relative to the canonical C. neoformans strain H99 (McFadden, De Jesus and Casadevall 2006), C. gattii capsules can be very similar (NIH191 and NIH198; Frases et al.2009), much smaller (strains CN23/10.993 and the PNW strain R265 (Cheng, Sham and Kronstad 2009; Fonseca et al.2010)) or significantly larger (strain I23 and R265; Frazzitta et al.2013).

Although the major capsular polysaccharide GXM is generally immunosuppressive, fractions with molecular masses below 10 000 Daltons isolated from C. gattii strains were effective in stimulating nitric oxide (NO) production by host macrophages and in activation of TLRs (TLR2/1 and TLR2/6) and NF-κB (Fonseca et al.2010). Increased production of NO has also been observed after incorporation of extracellular vesicles (EVs) by murine macrophages, but it was diminished after adding fractions of GXM (Oliveira et al.2010), suggesting that these two components may act in concert to reduce host inflammatory responses.

Interestingly, the cryptococcal capsule is also likely to play an important role in the environment. On plant surfaces, some strains of C. gattii form 40–100 nm length extracellular fibrils which then allow yeast cells to escape from human neutrophils in vivo, potentially by inhibiting the production of neutrophil extracellular traps (Rocha et al.2015). Consequently, infection of mice with yeast cells grown on leaf agar was more severe and showed higher proliferation in the lung and brain then when yeast cells grown on YPD agar were used (Springer et al.2010).

EXTRACELLULAR VESICLES

GXM, the main polysaccharide component of the cryptococcal capsule, is synthesized intracellularly and transferred from the Golgi apparatus (Hu et al.2007) to the outside of the cell wall via EVs (Yoneda and Doering 2006). The bilayered membrane-EVs serve not only as transporting ports for capsule components, but also are used by cryptococci as 20–400 nm diameter ‘virulence bags’ (Rodrigues et al.2007, 2008a). Studies performed so far on C. neoformans revealed that EVs contain ribosomal proteins as well as proteins related to virulence and anti-oxidant defense, including laccase (melanin synthesis), urease, superoxide dismutase and heat shock proteins (Rodrigues et al.2008a; and reviewed in Rodrigues et al.2014). Interestingly, a C. neoformans sec 6 RNAi mutant, which is impaired in EV secretion, was attenuated in virulence in mice, although growth at 37°C, capsule formation and phospholipase activity were not affected (Panepinto et al.2009). Recent studies on EVs from different fungi including C. neoformans revealed that these vesicles are packed with a spectrum of short non-coding mRNAs, which are thought to play a role in cell communication and pathogenesis (Peres da Silva et al.2015). Unfortunately, there is no data regarding function and content of EVs isolated from C. gattii to date.

On the other hand, cryptococcal EVs can enhance host anti-microbial activity after incorporation by murine macrophages where increased levels of NO and cytokines (extracellular TNF-α, IL-10 and transforming growth factor TGF-β) were observed (Oliveira et al.2010). Similar results were obtained after treatment of macrophages with EVs isolated from Candida albicans (Vargas et al.2015) suggesting that EVs can serve as a platform of secreted virulence for pathogenic fungi.

At first glance, enhancing host phagocytosis in this way seems like a disadvantageous step for a pathogen. However, since C. gattii can happily survive within the phagosome and, at the same time, be protected from other immune cells as well as extracellular anti-fungal molecules such as complement, it may be that EV-induced boosting of phagocytosis offers survival advantages to pathogens such as C. neoformans and C. albicans by facilitating their entry into an intracellular niche (Oliveira et al.2010; Vargas et al.2015).

SURVIVAL WITHIN MACROPHAGES

Although Cryptococci are phagocytosed by macrophages, in most cases they can then survive and proliferate inside these host cells. Cryptococci have developed an amazing repertoire of anti-phagocytic strategies (reviewed in Johnston and May 2013), most probably as a result of prolonged selective pressure from environmental predators such as amoebae (Steenbergen, Shuman and Casadevall 2001). As a result, virulence and defense mechanisms against phagocytic cells could be acquired and selected during the evolution of fungus–amoebal interactions in the environment. In support of this model, transcriptional profiles show strong similarities between genes upregulated by yeast internalized by amoebae and murine macrophages (Derengowski Lda et al.2013). Interestingly, however, relative to C. neoformans, C. gattii is rarely phagocytosed by the model amoeba Acanthamoeba castellanii, perhaps reflecting differences in their capsule structure (Malliaris, Steenbergen and Casadevall 2004).

FUNGAL PERSISTENCE AND REACTIVATION

Cryptococcus neoformans is classically thought of as a long-term latent pathogen that reactivates upon immunocompromisation, but this picture is more complex for C. gattii. Recent multilocus sequence typing between European and worldwide isolates has revealed that dormant C. gattii infections can be reactivated many years after the initial infection (Hagen et al.2012), for instance following treatment with corticosteroids (Hagen et al.2010). However, unlike C. neoformans, it appears that many C. gattii infections represent de novo acquisition of the organism from the environment, rather than (re)activation of latent disease (MacDougall and Fyfe 2006).

PROLIFERATION INSIDE MACROPHAGES AND ‘DIVISION OF LABOR’

All pathogenic Cryptococci appear capable of survival and proliferation within macrophages. However, outbreak C. gattii isolates are capable of intracellular proliferation rates that exceed those of all other isolates and which correlate with virulence (Ma et al.2009). In contrast, C. neoformans virulence is associated to macrophage uptake and laccase activity, but not to intracellular proliferation rate (IPR; Sabiiti et al.2014). This difference offers a potential explanation for their varying host profiles; C. gattii infections in otherwise healthy individuals can only proceed if intracellular proliferation is rapid enough to overwhelm the host immune system. In contrast, C. neoformans infections in immunocompromised hosts instead rely on ‘stealth’, in which rapid proliferation is not necessarily beneficial but an intracellular niche is critical for survival.

In the case of C. gattii outbreak isolates, rapid intracellular proliferation is associated with changes in mitochondrial morphology (Ma et al.2009; Voelz et al.2014). It was initially proposed that this change in mitochondrial morphology could protect the pathogen against the intracellular environment of the phagocytic cells (Ma et al.2009; Ma and May 2010). However, more recent analyses of this group have indicated a more complex and intriguing model. Upon entry into host phagocytes PNW outbreak strains of C. gattii trigger a ‘division of labor’ mechanism in which some cells adopt this mitochondrial morphology and cease division, but in doing so they facilitate extremely rapid proliferation of neighboring Cryptococci, thus driving amplification of the population as a whole (Fig. 3 ; Voelz et al.2014).

Figure 3.

Diagram representing a scheme of ‘division of labor’ during engulfment of cryptococcal cell by a macrophage. (A) Receptor-mediated phagocytosis allows recognition of the fungal cell. (B) Phagocytosis of the pathogen cell by an alveolar macrophage. (C) One of the first steps of host defense is an oxidative burst during when macrophage releases reactive oxygen species. (D) A subpopulation of guardian cells sacrifice their proliferation and tubularize their mitochondria which is accompanied with reduction of host ROS (E) This allows proliferation of neighboring cryptococcal cells (F) and following escape from the macrophage.

Surprisingly, a comparison of mitochondrial genomes between C. gattii and C. neoformans revealed similar gene content (D'Souza et al.2011). Likewise, a very recent whole genome analysis did not identify any single gene that is characteristic of the PNW strains (Farrer et al.2015). However, several studies have highlighted unusual patterns of mitochondrial inheritance and recombination in this lineage (Bovers et al.2009; Xu, Yan and Guo 2009; Voelz et al.2013), suggesting that unusual combinations of nuclear and mitochondrial alleles may contribute to the virulence of this group.

Interestingly, the inheritance patterns of mitochondria in C. gattii can be influenced by several environmental variables including UV exposure and higher temperatures (Wang, Wilson and Xu 2015), suggesting an intriguing link between environmental conditions and the evolution of novel genotypes in this group.

ESCAPING

In addition to intracellular proliferation, Cryptococci can also escape from host cells in a poorly understood process called vomocytosis (Alvarez and Casadevall 2006; Ma et al.2006). Interestingly, the frequency of this non-lytic expulsion process in vivo seems to be higher than the rates obtained in vitro (Nicola et al.2011). There is considerable interest in the contribution that vomocytosis may make to tissue dissemination by allowing infected phagocytes to ‘deposit’ Cryptococci at distant sites; the so-called Trojan Horse model. Charlier and colleagues have previously provided evidence for this mechanism of entry across the blood–brain barrier (Charlier et al.2009), although recent work using C. neoformans mutants with reduced phagocytosis by macrophages showed no difference in rates of CNS entry (Tseng et al.2012). Both C. neoformans and C. gattii undergo vomocytosis in vitro, and rates appear similar, at least between C. neoformans H99 and C. gattii R265 (Voelz, Lammas and May 2009) suggesting that differential vomocytosis is unlikely to be a major factor in PNW virulence. Rather, it appears that the slower growth of PNW C. gattii isolates in blood (10–100 times slower than C. neoformans) coupled with their exceptionally fast replication within host cells means that C. gattii infections frequently present as pulmonary infections rather than disseminated CNS disease (Ngamskulrungroj et al.2012; Sorrell et al.2015).

CELL GIGANTISM

Enlargement of the cryptococcal capsule has been documented as a mechanism of protection against phagocytosis and the phagocytic oxidative burst for many years (Zaragoza et al.2008). However, recently an additional role for cell size increase has become apparent. During in vivo infections, giant or ‘titan’ cells (50–100 μm in diameter) form and represent about 20% of the cryptococcal population during pulmonary infection (Okagaki et al.2010; Zaragoza et al.2010). Intriguingly, the presence of titan cells in the cryptococcal population reduces overall phagocytosis (not just of the titan cells themselves) by macrophages (Okagaki and Nielsen 2012). Recent studies using the moth larvae G. mellonella showed that during C. gattii infections, both the capsule and the cell sizes of VGII cells underwent significant enlargements up to 75 μm, but this was not observed in a very virulent PNW isolate R265 (Firacative, Duan and Meyer 2014). These observations are consistent with a suggestion that cell ‘titanisation’ provides an additional defense mechanism of the isolates attenuated in virulence (Evans et al.2015) and/or that this strategy is critical for long-term latent infections, but perhaps less vital for highly virulent acute infections caused by PNW strains.

CONCLUSIONS

Recent epidemiological data indicate that the PNW outbreak of C. gattii infection is receding, although the fungus now appears endemic to Vancouver Island (Espinel-Ingroff and Kidd 2015; Kwon-Chung and Saijo 2015), However, understanding the apparently recent and dramatic evolutionary history of virulent VGIIa isolates is of profound importance both for improving our understanding of fungal pathogenesis (Fig. 4) in general and for determining the likelihood of other such outbreaks in the near future.

Figure 4.

A cartoon representing a repertoire of cryptococcal pathogenic activities.

FUNDING

The authors are supported by funding from the European Research Council Award ‘MitoFun’ (RCM & EB) and by a Lister Institute Fellowship and a Royal Society Wolfson Merit Award (RCM).

Conflict of interest. None declared.

REFERENCES

Alvarez
M
Casadevall
A.
Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages
Curr Biol
2006
16
2161
5

Angkasekwinai
P
Sringkarin
N
Supasorn
O
et al. 
Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts
Infect Immun
2014
82
3880
90

Barchiesi
F
Cogliati
M
Esposto
MC
et al. 
Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis
J Infect
2005
51
10
6

Biemont
C.
A brief history of the status of transposable elements: from junk DNA to major players in evolution
Genetics
2010
186
1085
93

Billmyre
RB
Croll
D
Li
W
et al. 
Highly recombinant VGII Cryptococcus gattii population develops clonal outbreak clusters through both sexual macroevolution and asexual microevolution
mBio
2014
5
e01494
14

Boekhout
T
Theelen
B
Diaz
M
et al. 
Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans
Microbiology
2001
147
891
907

Bovers
M
Hagen
F
Kuramae
EE
et al. 
Promiscuous mitochondria in Cryptococcus gattii
FEMS Yeast Res
2009
9
489
503

Byrnes
EJ
III
Marr
KA
The outbreak of Cryptococcus gattii in Western North America: epidemiology and clinical issues
Curr Infect Dis Rep
2011
13
256
61

Callejas
A
Ordonez
N
Rodriguez
MC
et al. 
First isolation of Cryptococcus neoformans var. gattii, serotype C, from the environment in Colombia
Med Mycol
1998
36
341
4

Charlier
C
Nielsen
K
Daou
S
et al. 
Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans
Infect Immun
2009
77
120
7

Chen
S
Sorrell
T
Nimmo
G
et al. 
Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group
Clin Infect Dis
2000
31
499
508

Chen
SC
Korman
TM
Slavin
MA
et al. 
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii
Clin Infect Dis
2013a
57
543
51

Chen
SC
Slavin
MA
Heath
CH
et al. 
Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death
Clin Infect Dis
2012
55
789
98

Chen
YL
Lehman
VN
Lewit
Y
et al. 
Calcineurin governs thermotolerance and virulence of Cryptococcus gattii
G3
2013b
3
527
39

Cheng
PY
Sham
A
Kronstad
JW
Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans
Infect Immun
2009
77
4284
94

Costa
MC
Fernandes
HB
Silveira
RR
et al. 
Gender influence on the macrophages interaction with Cryptococcus gattii
XXVIII Congresso Brasileiro Microbiologia CBM
2015

D'Souza
CA
Kronstad
JW
Taylor
G
et al. 
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts
mBio
2011
2
e00342
10

Da Silva
CA
Hartl
D
Liu
W
et al. 
TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation
J Immunol
2008
181
4279
86

De Jesus
M
Chow
SK
Cordero
RJ
et al. 
Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable
Eukaryot Cell
2010
9
1018
28

De Jesus
M
Nicola
AM
Rodrigues
ML
et al. 
Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan
Eukaryot Cell
2009
8
96
103

Derengowski Lda
S
Paes
HC
Albuquerque
P
et al. 
The transcriptional response of Cryptococcus neoformans to ingestion by Acanthamoeba castellanii and macrophages provides insights into the evolutionary adaptation to the mammalian host
Eukaryot Cell
2013
12
761
74

Diaz
MR
Boekhout
T
Kiesling
T
et al. 
Comparative analysis of the intergenic spacer regions and population structure of the species complex of the pathogenic yeast Cryptococcus neoformans
FEMS Yeast Res
2005
5
1129
40

Diaz
MR
Boekhout
T
Theelen
B
et al. 
Molecular sequence analyses of the intergenic spacer (IGS) associated with rDNA of the two varieties of the pathogenic yeast, Cryptococcus neoformans
Syst Appl Microbiol
2000
23
535
45

Dumesic
PA
Natarajan
P
Chen
C
et al. 
Stalled spliceosomes are a signal for RNAi-mediated genome defense
Cell
2013
152
957
68

Ellis
DH
Pfeiffer
TJ.
Natural habitat of Cryptococcus neoformans var. gattii
J Clin Microbiol
1990
28
1642
4

Engelthaler
DM
Hicks
ND
Gillece
JD
et al. 
Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal
mBio
2014
5
e01464
14

Espinel-Ingroff
A
Kidd
SE.
Current trends in the prevalence of Cryptococcus gattii in the United States and Canada
Infect DrugResist
2015
8
89
97

Evans
RJ
Li
Z
Hughes
WS
et al. 
Cryptococcal phospholipase B1 is required for intracellular proliferation and control of titan cell morphology during macrophage infection
Infect Immun
2015
83
1296
304

Farrer
RA
Desjardins
CA
Sakthikumar
S
et al. 
Genome evolution and innovation across the four major lineages of Cryptococcus gattii
mBio
2015
6
e00868
15

Firacative
C
Duan
S
Meyer
W.
Galleria mellonella model identifies highly virulent strains among all major molecular types of Cryptococcus gattii
PLoS One
2014
9
e105076

Fonseca
FL
Nohara
LL
Cordero
RJ
et al. 
Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter
Infect Immun
2010
78
3861
70

Franzot
SP
Salkin
IF
Casadevall
A
Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates
J Clin Microbiol
1999
37
838
40

Fraser
JA
Giles
SS
Wenink
EC
et al. 
Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak
Nature
2005
437
1360
4

Fraser
JA
Subaran
RL
Nichols
CB
et al. 
Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada
Eukaryot Cell
2003
2
1036
45

Frases
S
Pontes
B
Nimrichter
L
et al. 
Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules
P Natl Acad Sci USA
2009
106
1228
33

Frazzitta
AE
Vora
H
Price
MS
et al. 
Nitrogen source-dependent capsule induction in human-pathogenic cryptococcus species
Eukaryot Cell
2013
12
1439
50

Galanis
E
Macdougall
L
Kidd
S
et al. 
Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007
Emerg Infect Dis
2010
16
251
7

Garcia-Hermoso
D
Dromer
F
Janbon
G
Cryptococcus neoformans capsule structure evolution in vitro and during murine infection
Infect Immun
2004
72
3359
65

Garcia-Rodas
R
Cordero
RJ
Trevijano-Contador
N
et al. 
Capsule growth in Cryptococcus neoformans is coordinated with cell cycle progression
mBio
2014
5
e00945
14

Garcia-Solache
MA
Izquierdo-Garcia
D
Smith
C
et al. 
Fungal virulence in a lepidopteran model is an emergent property with deterministic features
mBio
2013
4
e00100
13

Granger
DL
Perfect
JR
Durack
DT.
Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide
J Clin Invest
1985
76
508
16

Gupta
G
Fries
BC.
Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis
Future Microbiol
2010
5
775
87

Hagen
F
Boekhout
T
The search for the natural habitat of Cryptococcus gattii
Mycopathologia
2010
170
209
11

Hagen
F
Ceresini
PC
Polacheck
I
et al. 
Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest
PLoS One
2013
8
e71148

Hagen
F
Colom
MF
Swinne
D
et al. 
Autochthonous and dormant Cryptococcus gattii infections in Europe
Emerg Infect Dis
2012
18
1618
24

Hagen
F
Khayhan
K
Theelen
B
et al. 
Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex
Fungal Genet Biol
2015
78
16
48

Hagen
F
van Assen
S
Luijckx
GJ
et al. 
Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach
Med Mycol
2010
48
528
31

Harris
J
Lockhart
S
Chiller
T.
Cryptococcus gattii: where do we go from here?
Med Mycol
2012
50
113
29

Harris
JR
Lockhart
SR
Debess
E
et al. 
Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen
Clin Infect Dis
2011
53
1188
95

Hoang
LM
Maguire
JA
Doyle
P
et al. 
Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997–2002): epidemiology, microbiology and histopathology
J Med Microbiol
2004
53
935
40

Hu
G
Steen
BR
Lian
T
et al. 
Transcriptional regulation by protein kinase A in Cryptococcus neoformans
PLoS Pathog
2007
3
e42

Huerfano
S
Castaneda
A
Castaneda
E.
Experimental infection of almond trees seedlings (Terminalia catappa) with an environmental isolate of Cryptococcus neoformans var. gattii, serotype C
Rev Iberoam Micol
2001
18
131
2

Huston
SM
Li
SS
Stack
D
et al. 
Cryptococcus gattii is killed by dendritic cells, but evades adaptive immunity by failing to induce dendritic cell maturation
J Immunol
2013
191
249
61

Ito-Kuwa
S
Nakamura
K
Aoki
S
et al. 
Serotype identification of Cryptococcus neoformans by multiplex PCR
Mycoses
2007
50
277
81

Iverson
SA
Chiller
T
Beekmann
S
et al. 
Recognition and diagnosis of Cryptococcus gattii infections in the United States
Emerg Infect Dis
2012
18
1012
5

Janbon
G
Maeng
S
Yang
DH
et al. 
Characterizing the role of RNA silencing components in Cryptococcus neoformans
Fungal Genet Biol
2010
47
1070
80

Johnston
SA
May
RC.
Cryptococcus interactions with macrophages: evasion and manipulation of the phagosome by a fungal pathogen
Cell Microbiol
2013
15
403
11

Kidd
SE
Hagen
F
Tscharke
RL
et al. 
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)
P Natl Acad Sci USA
2004
101
17258
63

Kozel
TR
Mastroianni
RP.
Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis
Infect Immun
1976
14
62
7

Kwon-Chung
KJ
Bennett
JE.
High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions
Zbl Bakt-Int J Med M
1984
257
213
8

Kwon-Chung
KJ
Edman
JC
Wickes
BL.
Genetic association of mating types and virulence in Cryptococcus neoformans
Infect Immun
1992
60
602
5

Kwon-Chung
KJ
Fraser
JA
Doering
TL
et al. 
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis
Cold Spring Harb Perspect Med
2014
4
a019760

Kwon-Chung
KJ
Polacheck
I
Bennett
JE.
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C)
J Clin Microbiol
1982
15
535
7

Kwon-Chung
KJ
Saijo
T.
Is Cryptococcus gattii a primary pathogen?
J Fungi
2015
1
154
67

Kwon-Chung
KJ
Varma
A.
Do major species concepts support one, two or more species within Cryptococcus neoformans?
FEMS Yeast Res
2006
6
574
87

Lin
X
Hull
CM
Heitman
J.
Sexual reproduction between partners of the same mating type in Cryptococcus neoformans
Nature
2005
434
1017
21

Liu
J
Farmer
JD
Lane
WS
et al. 
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Cell
1991
66
807
15

Lizarazo
J
Escandon
P
Agudelo
CI
et al. 
Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997–2011
PLoS Negl Trop Dis
2014
8
e3272

Lockhart
SR
Iqbal
N
Harris
JR
et al. 
Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates
PLoS One
2013
8
e74737

Ma
H
Croudace
JE
Lammas
DA
et al. 
Expulsion of live pathogenic yeast by macrophages
Curr Biol
2006
16
2156
60

Ma
H
Hagen
F
Stekel
DJ
et al. 
The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation
P Natl Acad Sci USA
2009
106
12980
5

Ma
H
May
RC.
Mitochondria and the regulation of hypervirulence in the fatal fungal outbreak on Vancouver Island
Virulence
2010
1
197
201

McClelland
EE
Bernhardt
P
Casadevall
A.
Estimating the relative contributions of virulence factors for pathogenic microbes
Infect Immun
2006
74
1500
4

McClelland
EE
Hobbs
LM
Rivera
J
et al. 
The role of host gender in the pathogenesis of Cryptococcus neoformans infections
PLoS One
2013
8
e63632

McFadden
DC
De Jesus
M
Casadevall
A.
The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction
J Biol Chem
2006
281
1868
75

McTaggart
L
Richardson
SE
Seah
C
et al. 
Rapid identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by use of rapid biochemical tests, differential media, and DNA sequencing
J Clin Microbiol
2011
49
2522
7

MacDougall
L
Fyfe
M
Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period
J Clin Microbiol
2006
44
1851
2

MacDougall
L
Fyfe
M
Romney
M
et al. 
Risk factors for Cryptococcus gattii infection, British Columbia, Canada
Emerg Infect Dis
2011
17
193
9

MacDougall
L
Kidd
SE
Galanis
E
et al. 
Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA
Emerg Infect Dis
2007
13
42
50

Malik
R
Speed
BR
Kaldor
J
et al. 
Serum antibody response to Cryptococcus neoformans in cats, dogs and koalas with and without active infection
Med Mycol
1999
37
43
51

Malliaris
SD
Steenbergen
JN
Casadevall
A.
Cryptococcus neoformans var. gattii can exploit Acanthamoeba castellanii for growth
Med Mycol
2004
42
149
58

Marr
KA
Datta
K
Pirofski
LA
et al. 
Cryptococcus gattii infection in healthy hosts: a sentinel for subclinical immunodeficiency?
Clin Infect Dis
2012
54
153
4

Meyer
W
Castaneda
A
Jackson
S
et al. 
Molecular typing of IberoAmerican Cryptococcus neoformans isolates
Emerg Infect Dis
2003
9
189
95

Meyer
W
Marszewska
K
Amirmostofian
M
et al. 
Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA-a pilot study to standardize techniques on which to base a detailed epidemiological survey
Electrophoresis
1999
20
1790
9

Min
KH
Kwon-Chung
KJ.
The biochemical basis for the distinction between the two Cryptococcus neoformans varieties with CGB medium
Zbl Bakt-Int J Med M
1986
261
471
80

Mitchell
DH
Sorrell
TC
Allworth
AM
et al. 
Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome
Clin Infect Dis
1995
20
611
6

Ngamskulrungroj
P
Chang
Y
Sionov
E
et al. 
The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model
mBio
2012
3
e00103
12

Ngamskulrungroj
P
Sorrell
TC
Chindamporn
A
et al. 
Association between fertility and molecular sub-type of global isolates of Cryptococcus gattii molecular type VGII
Med Mycol
2008
46
665
73

Nicola
AM
Robertson
EJ
Albuquerque
P
et al. 
Nonlytic exocytosis of Cryptococcus neoformans from macrophages occurs in vivo and is influenced by phagosomal pH
mBio
2011
2
e00167
11

Nicolas
FE
Torres-Martinez
S
Ruiz-Vazquez
RM.
Loss and retention of RNA interference in fungi and parasites.
PLoS Pathog
2013
9
e1003089

Nielsen
K
Marra
RE
Hagen
F
et al. 
Interaction between genetic background and the mating-type locus in Cryptococcus neoformans virulence potential
Genetics
2005
171
975
83

Okagaki
LH
Nielsen
K.
Titan cells confer protection from phagocytosis in Cryptococcus neoformans infections
Eukaryot Cell
2012
11
820
6

Okagaki
LH
Strain
AK
Nielsen
JN
et al. 
Cryptococcal cell morphology affects host cell interactions and pathogenicity
PLoS Pathog
2010
6
e1000953

Oliveira
DL
Freire-de-Lima
CG
Nosanchuk
JD
et al. 
Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions
Infect Immun
2010
78
1601
9

Oliver
KR
Greene
WK.
Transposable elements: powerful facilitators of evolution
BioEssays
2009
31
703
14

Panepinto
J
Komperda
K
Frases
S
et al. 
Sec 6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans
Mol Microbiol
2009
71
1165
76

Pappas
PG.
Cryptococcal infections in non-HIV-infected patients
Trans Am Clin Climatol Assoc
2013
124
61
79

Park
BJ
Wannemuehler
KA
Marston
BJ
et al. 
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
AIDS
2009
23
525
30

Peres da Silva
R
Puccia
R
Rodrigues
ML
et al. 
Extracellular vesicle-mediated export of fungal RNA
Sci Rep
2015
5
7763

Phillips
P
Galanis
E
MacDougall
L
et al. 
Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia
Clin Infect Dis
2015
60
1368
76

Rivera
J
Feldmesser
M
Cammer
M
et al. 
Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection
Infect Immun
1998
66
5027
30

Rocha
JD
Nascimento
MT
Decote-Ricardo
D
et al. 
Capsular polysaccharides from Cryptococcus neoformans modulate production of neutrophil extracellular traps (NETs) by human neutrophils
Sci Rep
2015
5
8008

Rodrigues
ML
Alvarez
M
Fonseca
FL
et al. 
Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan
Eukaryot Cell
2008a
7
602
9

Rodrigues
ML
Nakayasu
ES
Almeida
IC
et al. 
The impact of proteomics on the understanding of functions and biogenesis of fungal extracellular vesicles
J Proteomics
2014
97
177
86

Rodrigues
ML
Nakayasu
ES
Oliveira
DL
et al. 
Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence
Eukaryot Cell
2008b
7
58
67

Rodrigues
ML
Nimrichter
L
Oliveira
DL
et al. 
Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport
Eukaryot Cell
2007
6
48
59

Rosen
LB
Freeman
AF
Yang
LM
et al. 
Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis
J Immunol
2013
190
3959
66

Sabiiti
W
Robertson
E
Beale
MA
et al. 
Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis
J Clin Invest
2014
124
2000
8

Saijo
T
Chen
J
Chen
SC
et al. 
Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients
mBio
2014
5
e00912
4

Schoffelen
T
Illnait-Zaragozi
MT
Joosten
LA
et al. 
Cryptococcus gattii induces a cytokine pattern that is distinct from other cryptococcal species
PLoS One
2013
8
e55579

Sorrell
TC.
Cryptococcus neoformans variety gattii
Med Mycol
2001
39
155
68

Sorrell
TC
Chen
SC
Recent advances in management of cryptococcal meningitis: commentary
F1000 Med Rep
2010
2
82

Sorrell
TC
Juillard
PG
Djordjevic
JT
et al. 
Cryptococcal transmigration across a model brain blood-barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265
Microbes Infect
2015
15
e00189
6

Speed
B
Dunt
D
Clinical and host differences between infections with the two varieties of Cryptococcus neoformans
Clin Infect Dis
1995
21
28
34

Speed
BR
Kaldor
J
Cairns
B
et al. 
Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects
J Med Vet Mycol
1996
34
187
93

Springer
DJ
Chaturvedi
V
Projecting global occurrence of Cryptococcus gattii
Emerg Infect Dis
2010
16
14
20

Springer
DJ
Ren
P
Raina
R
et al. 
Extracellular fibrils of pathogenic yeast Cryptococcus gattii are important for ecological niche, murine virulence and human neutrophil interactions
PLoS One
2010
5
e10978

Steenbergen
JN
Shuman
HA
Casadevall
A.
Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages
P Natl Acad Sci USA
2001
98
15245
50

Stephen
C
Lester
S
Black
W
et al. 
Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia
Can Vet J
2002
43
792
4

Syme
RM
Bruno
TF
Kozel
TR
et al. 
The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody
Infect Immun
1999
67
4620
7

Tintelnot
K
Hagen
F
Han
CO
et al. 
Pitfalls in serological diagnosis of Cryptococcus gattii infections
Med Mycol
2015
53
874
9

Trilles
L
Meyer
W
Wanke
B
et al. 
Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex
Med Mycol
2012
50
328
32

Tseng
HK
Liu
CP
Price
MS
et al. 
Identification of genes from the fungal pathogen Cryptococcus neoformans related to transmigration into the central nervous system
PLoS One
2012
7
e45083

Upton
A
Fraser
JA
Kidd
SE
et al. 
First contemporary case of human infection with Cryptococcus gattii in Puget Sound: evidence for spread of the Vancouver Island outbreak
J Clin Microbiol
2007
45
3086
8

Vargas
G
Rocha
JD
Oliveira
DL
et al. 
Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans
Cell Microbiol
2015
17
389
407

Vartivarian
SE
Anaissie
EJ
Cowart
RE
et al. 
Regulation of cryptococcal capsular polysaccharide by iron
J Infect Dis
1993
167
186
90

Vartivarian
SE
Reyes
GH
Jacobson
ES
et al. 
Localization of mannoprotein in Cryptococcus neoformans
J Bacteriol
1989
171
6850
2

Vecchiarelli
A.
The cellular responses induced by the capsular polysaccharide of Cryptococcus neoformans differ depending on the presence or absence of specific protective antibodies
Curr Mol Med
2005
5
413
20

Vecchiarelli
A
Pericolini
E
Gabrielli
E
et al. 
Elucidating the immunological function of the Cryptococcus neoformans capsule
Future Microbiol
2013
8
1107
16

Vecchiarelli
A
Retini
C
Monari
C
et al. 
Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes
Infect Immun
1996
64
2846
9

Vecchiarelli
A
Retini
C
Pietrella
D
et al. 
Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes
Infect Immun
1995
63
2919
23

Voelz
K
Johnston
SA
Smith
LM
et al. 
‘Division of labour’ in response to host oxidative burst drives a fatal Cryptococcus gattii outbreak
Nat Commun
2014
5
5194

Voelz
K
Lammas
DA
May
RC.
Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans
Infect Immun
2009
77
3450
7

Voelz
K
Ma
H
Phadke
S
et al. 
Transmission of Hypervirulence traits via sexual reproduction within and between lineages of the human fungal pathogen cryptococcus gattii
PLoS Genet
2013
9
e1003771

Wang
X
Hsueh
YP
Li
W
et al. 
Sex-induced silencing defends the genome of Cryptococcus neoformans via RNAi
Genes Dev
2010
24
2566
82

Wang
X
Wang
P
Sun
S
et al. 
Transgene induced co-suppression during vegetative growth in Cryptococcus neoformans
PLoS Genet
2012
8
e1002885

Wang
Z
Wilson
A
Xu
J.
Mitochondrial DNA inheritance in the human fungal pathogen Cryptococcus gattii
Fungal Genet Biol
2015
75
1
10

Weiberg
A
Wang
M
Lin
FM
et al. 
Fungal small RNAs suppress plant immunity by hijacking host RNA interference pathways
Science
2013
342
118
23

Wiesner
DL
Moskalenko
O
Corcoran
JM
et al. 
Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis
mBio
2012
3
e00196
12

Xu
J
Yan
Z
Guo
H.
Divergence, hybridization, and recombination in the mitochondrial genome of the human pathogenic yeast Cryptococcus gattii
Mol Ecol
2009
18
2628
42

Xue
C
Tada
Y
Dong
X
et al. 
The human fungal pathogen Cryptococcus can complete its sexual cycle during a pathogenic association with plants
Cell Host Microbe
2007
1
263
73

Yoneda
A
Doering
TL.
A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis
Mol Biol Cell
2006
17
5131
40

Zaragoza
O
Casadevall
A.
Experimental modulation of capsule size in Cryptococcus neoformans
Biol Proced Online
2004
6
10
5

Zaragoza
O
Chrisman
CJ
Castelli
MV
et al. 
Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival
Cell Microbiol
2008
10
2043
57

Zaragoza
O
Fries
BC
Casadevall
A.
Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2)
Infect Immun
2003
71
6155
64

Zaragoza
O
Garcia-Rodas
R
Nosanchuk
JD
et al. 
Fungal cell gigantism during mammalian infection
PLoS Pathog
2010
6
e1000945

Zhu
P
Zhai
B
Lin
X
et al. 
Congenic strains for genetic analysis of virulence traits in Cryptococcus gattii
Infect Immun
2013
81
2616
25